Analysis of NORBEN TEA & EXPORTS LTD. (NORBTEAEXP)
NORBEN TEA & EXPORTS LTD. has been showing some volatility in its stock price recently. The Relative Strength Index (RSI) values have been fluctuating around the mid-range, indicating a lack of strong trend in either direction. The Moving Average Convergence Divergence (MACD) indicator has been hovering around the zero line, suggesting a balance between bullish and bearish momentum.
The stock price has been moving within a range, with the price closing near the opening price on most days. The Moving Average (MA) indicator has been relatively stable, indicating a lack of significant trend in the short term.
Overall, based on the provided data, it seems that NORBEN TEA & EXPORTS LTD. is currently experiencing a period of consolidation and uncertainty in its stock price movement. Further analysis and monitoring of key technical indicators may be needed to identify potential future trends.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods, with slightly higher growth expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided:
- The current year growth rate is 7.5%
- The next quarter growth rate is 4.8%
- The current quarter growth rate is 5.6%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 11%
- The past 5 years compound annual growth rate (CAGR) is 20.15%
It can be observed that the growth rates are expected to vary across different periods, with a higher growth rate projected for the next 5 years compared to the current and past performance. The company is expected to experience a significant growth spurt in the coming years based on these estimates.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and price-to-book ratio. The company's market capitalization and enterprise value are substantial, with moderate price-to-sales and enterprise-to-EBITDA ratios.
The stock price summary includes beta, moving averages, and the range of prices over the past year.
Lastly, dividends and splits information shows the company's dividend history, payout ratio, and dividend yield metrics. The company has a regular dividend payment schedule and has undergone a stock split in the past.
Income statement 💸
These are the revenues. Here are the conclusions:
1. The company's sales have been increasing steadily over the past four years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, ranging from 38% to 44% over the same period.
3. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has increased from $57.4 billion in 2020 to $97 billion in 2023, indicating improving profitability.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
6. The company has been able to manage its operating expenses effectively, with a slight increase in absolute terms but a decrease in percentage of sales.
7. Overall, the financial performance of the company in terms of revenues has been positive, showing growth and improving profitability.
Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:
1. The total assets have been increasing over the years, indicating growth in the company's overall value.
2. Current assets have fluctuated, with some years showing higher cash reserves and others showing higher inventory levels.
3. Non-current assets have generally increased, with investments and advances being a significant portion of the assets.
4. Total liabilities have also been on the rise, but at a slower pace compared to total assets.
5. Shareholders' equity has shown variations, influenced by factors such as common stock, retained earnings, and other equity components.
6. The company has been managing its short-term and long-term debts, with fluctuations in the amounts over the years.
7. The provision for risks and charges has also varied, indicating changes in the company's risk management strategies.
8. Overall, the company seems to be growing steadily, with a focus on managing its assets, liabilities, and equity to ensure financial stability and growth.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been relatively stable over the years, indicating consistent operational performance.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020 and its lowest in 2022.
5. Financing activities show significant variations, with large amounts being spent on common stock repurchase and debt issuance/payments.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company's cash flow statement reflects a mix of stable operational performance, significant financing activities, and varying investment decisions over the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive outlook with an increase in earnings per share expected for both the next quarter and the next year compared to the previous periods. The number of analysts providing estimates also indicates a strong interest in the company's performance.MACD of NORBTEAEXP